We are live on
!
Find out more
GFA
Gifford Fong Associates Portfolio holdings
AUM
$501M
1-Year Est. Return
32.77%
This Fund
S&P 500
This Quarter
Est. Return
+23.98%
1 Year Est. Return
+32.77%
3 Year Est. Return
+180.45%
5 Year Est. Return
+217.25%
10 Year Est. Return
–
AUM
$330M
AUM Growth
+$57.5M
(+21%)
Cap. Flow
-$3.11M
Cap. Flow
% of AUM
-0.94%
Top 10 Holdings %
Top 10 Hldgs %
43.6%
Holding
130
New
3
Increased
6
Reduced
3
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$5.73M |
| 2 |
Microsoft
MSFT
|
+$3.3M |
| 3 |
NVIDIA
NVDA
|
+$3.24M |
| 4 |
Merck
MRK
|
+$1.58M |
| 5 |
Qualcomm
QCOM
|
+$802K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$10.9M |
| 2 |
Tesla
TSLA
|
+$8.11M |
| 3 |
RTX Corp
RTX
|
+$368K |
| 4 |
CHK
Chesapeake Energy Corporation
CHK
|
+$52K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.85% |
| 2 | Financials | 19.47% |
| 3 | Healthcare | 13.24% |
| 4 | Consumer Discretionary | 12.27% |
| 5 | Communication Services | 11.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Comcast
CMCSA
$90.4B
| $3.43M | 1.04% |
88,000
| – | – |
|
27
Citigroup
C
$231B
| $3.14M | 0.95% |
61,471
| – | – |
|
28
Emerson Electric
EMR
$91.4B
| $3.1M | 0.94% |
50,000
| – | – |
|
29
Biogen
BIIB
$30.9B
| $3.08M | 0.93% |
11,500
| – | – |
|
30
Synchrony
SYF
$25.8B
| $2.93M | 0.89% |
132,073
| – | – |
|
31
Meta Platforms (Facebook)
META
$1.47T
| $2.84M | 0.86% |
12,500
| – | – |
|
32
AbbVie
ABBV
$440B
| $2.74M | 0.83% |
27,900
| – | – |
|
33
Eli Lilly
LLY
$1.09T
| $2.64M | 0.8% |
16,100
| – | – |
|
34
Gilead Sciences
GILD
$168B
| $2.62M | 0.79% |
34,000
| – | – |
|
|
WBA
35
DELISTED
Walgreens Boots Alliance
WBA
| $2.54M | 0.77% |
60,000
| – | – |
|
36
Baxter International
BAX
$13.9B
| $2.5M | 0.76% |
29,000
| – | – |
|
37
Micron Technology
MU
$1.03T
| $2.31M | 0.7% |
44,800
| – | – |
|
38
GE Aerospace
GE
$379B
| $2.3M | 0.7% |
67,473
| – | – |
|
39
Wells Fargo
WFC
$269B
| $2.25M | 0.68% |
88,052
| – | – |
|
40
Pinnacle West Capital
PNW
$12.2B
| $2.2M | 0.67% |
30,000
| – | – |
|
41
Bristol-Myers Squibb
BMY
$130B
| $2.11M | 0.64% |
35,899
| – | – |
|
42
Lowe's Companies
LOW
$121B
| $2.07M | 0.63% |
15,320
| – | – |
|
43
Honeywell
HON
$74.6B
| $2.04M | 0.62% |
14,960
| – | – |
|
44
Chevron
CVX
$386B
| $1.98M | 0.6% |
22,200
| – | – |
|
45
Ford
F
$55.1B
| $1.98M | 0.6% |
325,000
| – | – |
|
46
Bausch Health
BHC
$2.32B
| $1.83M | 0.55% |
100,000
| – | – |
|
47
Abbott
ABT
$192B
| $1.77M | 0.54% |
19,400
| – | – |
|
|
48
Merck
MRK
$328B
| $1.77M | 0.54% |
23,999
+20,960
| +690% | +$1.58M |
|
49
AT&T
T
$166B
| $1.73M | 0.52% |
75,788
+33,100
| +78% | +$754K |
|
50
PepsiCo
PEP
$189B
| $1.72M | 0.52% |
13,000
| – | – |
|
Similar funds
HFA
VFPW
CIP
LRWA
VW
DE
MG
OP
Gifford Fong Associates's Q2 2020 Portfolio in Review
As of Q2 2020, Gifford Fong Associates held 130 positions worth $330M, up 21% from $273M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Trading was light in Q2 2020: portfolio turnover was 3.1%. Gifford Fong Associates opened 3 new positions and exited 1, leaving the 130-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Gifford Fong Associates's largest Q2 2020 buy was First Horizon: 50,000 shares worth $498K.
- Gifford Fong Associates added most to UnitedHealth in Q2 2020, an estimated $5.73M increase.
- Gifford Fong Associates's biggest Q2 2020 reduction was Amazon, cutting an estimated $10.9M.
- Gifford Fong Associates fully exited Chesapeake Energy Corporation in Q2 2020, selling an estimated $52K.
- Gifford Fong Associates's ten largest holdings make up 44% of its $330M portfolio in Q2 2020.
- Gifford Fong Associates opened 3 new positions and closed 1 in Q2 2020.
- Gifford Fong Associates's portfolio value rose 21% quarter-over-quarter to $330M.
Based on Gifford Fong Associates's 13F filing for Q2 2020, filed 14 Aug 2020.